MediWound Ltd. (NASDAQ:MDWD) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET

Company Participants

Monique Kosse - Investor Relations

Ofer Gonen - Chief Executive Officer

Boaz Gur-Lavie - Chief Financial Officer

Conference Call Participants

Bryan Bergin - Cowen

Ryan Zimmerman - BTIG

Arthur He - H.C. Wainwright

Operator

Good day and welcome to MediWound’s Second Quarter 2022 Earnings Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to Monique Kosse of LifeSci Advisors. Please go ahead.

Monique Kosse

Thank you, operator, and welcome, everyone. Earlier today, MediWound issued a press release announcing financial results for the second quarter ended June 30, 2022. You may access that release on the company’s website under the Investors tab.

With us today are Ofer Gonen, Chief Executive Officer of MediWound and Boaz Gur-Lavie, Chief Financial Officer. Following our prepared remarks, we will open the call for Q&A.

Before we begin, I would like to remind everyone that statements made during this call, including the Q&A session relating to MediWound’s expected future performance, future business prospects or future events or plans are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. Although the company believes that expectations reflected in such forward-looking statements are based upon reasonable assumptions, actual outcomes and results are subject to risks and uncertainties and could differ materially from those forecast due to the impact of many factors beyond the control of MediWound. The company assumes no obligation to update or supplement any forward-looking statements, whether as a result of new information, future events or otherwise. Participants are directed to cautionary notes set forth in today’s press release as well as the risk factors set forth in MediWound’s annual report filed with the SEC for factors that could cause actual results to differ materially from those anticipated in the forward-looking statements. The conference call is the property of MediWound, and any recording or rebroadcast is expressly prohibited without the written consent of MediWound.

Now I would like to turn the call over to Ofer Gonen, Chief Executive Officer of MediWound. Ofer?

Ofer Gonen

Thank you, Monique. Good morning, everyone. Welcome to our second quarter 2022 conference call to discuss our financial and operational highlights and provide you with our corporate updates.

I would like to begin by saying how proud I am of the accomplishments we made this quarter and note that this is my first earnings call as the new CEO of MediWound. May I add that my transition from being a board member to becoming a CEO has been very smooth. This quarter, we had positive news across all of our programs, and the company is on a strong trajectory.